KERA antibody (C-Term)
Quick Overview for KERA antibody (C-Term) (ABIN953035)
Target
See all KERA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 227-257, C-Term
-
Specificity
- This antibody recognizes Human Keratocan (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 227-257 amino acids from the C-terminal region of human Keratocan Genename: KERA
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- KERA (Keratocan (KERA))
-
Alternative Name
- Keratocan
-
Background
- The protein encoded by this gene is a keratan sulfate proteoglycan that is involved in corneal transparency. Defects in this gene are a cause of autosomal recessive cornea plana 2 (CNA2).Synonyms: KERA, KTN, Keratan sulfate proteoglycan keratocan, Keratocan, SLRR2B
-
Molecular Weight
- 40509 Da
-
Gene ID
- 11081
-
NCBI Accession
- NP_008966
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-